PRP for Shoulder and Rotator Cuff Disease: What the Clinical Trial Data Shows
- 2 days ago
- 5 min read
By Dr. Jeffrey Peng, MD · Published March 6, 2025 · 7 min read
Watch the Full Video
Rotator cuff disease is one of the most common causes of shoulder pain, accounting for up to 70% of all shoulder complaints. The condition spans a wide spectrum — from tendinopathy and subacromial impingement to partial and full-thickness tears — and the vast majority of cases can be managed without surgery. But when pain is severe enough to prevent participation in physical therapy, injections become a critical bridge to recovery.
For decades, cortisone injections have been the default option. However, growing evidence suggests that steroid injections provide only short-lived relief and may carry significant downsides — particularly for the tendons of the rotator cuff. When cortisone is injected without imaging guidance, it can come into contact with or infiltrate the tendon itself, potentially causing degradation that weakens the rotator cuff and complicates future surgical repair.
This has led many physicians, including myself, to look for better alternatives. One of the most promising is platelet-rich plasma (PRP). PRP has already demonstrated strong outcomes for conditions like tennis elbow, golfer's elbow, and hip tendinopathies. But its role in treating rotator cuff disease has been less clear — until more recent data started to emerge.
What Does This Meta-Analysis Tell Us About PRP for Rotator Cuff Disease?
A meta-analysis by Pang et al. (2023) published in Arthroscopy pooled data from thirteen randomized controlled trials involving 725 patients with rotator cuff disease. The study compared PRP injections head-to-head with corticosteroid injections across multiple outcome measures including functional scores, pain relief, range of motion, and tendon health.
The key findings were encouraging for PRP. At medium-term (2–6 months) and long-term (6+ months) follow-up, PRP led to statistically better functional scores compared to cortisone. This was reflected across several validated outcome measures including the Constant-Murley score, the ASES score, and the Simple Shoulder Test.
Does PRP Reduce Shoulder Pain Better Than Cortisone?
When it comes to pain reduction specifically, the meta-analysis found no statistically significant difference between PRP and cortisone injections at any time point. This means PRP provides comparable pain relief to steroids — without the potential tendon-damaging side effects.
This is an important finding. Many patients and clinicians assume cortisone is the superior option for quick pain relief. While steroids may offer slightly faster initial improvement, the data shows that PRP catches up and ultimately matches cortisone's analgesic effect while offering additional functional benefits over the medium and long term.
What About Range of Motion After PRP Injection?
The range of motion data was mixed. Only three of the thirteen studies reported medium-term range of motion outcomes. Of those three, two found that PRP produced superior improvements in range of motion compared to cortisone, while the third found no meaningful difference between the two treatments. More data is needed before definitive conclusions can be drawn about PRP's effect on shoulder mobility.
Can PRP Improve Rotator Cuff Tendon Health?
Five studies in the meta-analysis included ultrasound imaging to assess structural changes in the rotator cuff after treatment. The results were intriguing: one study found that PRP significantly reduced the frequency of partial tears and effusion on imaging. Another demonstrated a meaningful improvement in tendon lesion grading in the PRP group, with no corresponding improvement in the steroid group. A third study found no difference in tendon thickness at any follow-up time point.
While not every study showed a structural benefit, the overall trend suggests that PRP may have a protective or even regenerative effect on rotator cuff tendons — something cortisone injections simply cannot offer.
Does PRP Reduce the Need for Further Injections or Surgery?
One of the most clinically relevant findings was that PRP injections were associated with significantly lower rates of post-injection failure — meaning fewer patients in the PRP group went on to require additional injections or surgical intervention within the first twelve months. This suggests that PRP may provide a more durable treatment effect than cortisone, which often wears off and leaves patients seeking repeat injections.
Why Are PRP Results for the Shoulder Less Dramatic Than for Tennis Elbow?
If PRP works so well for conditions like tennis elbow and gluteal tendinopathy, why are the results for the shoulder not as overwhelmingly positive? In my view, there are two major reasons.
PRP concentration and quality are rarely standardized. Many of the studies included in this meta-analysis did not report the platelet concentration or the type of PRP kit used. This is a critical oversight. A 10 mg dose of a blood pressure medication will not produce the same result as a 100 mg dose of the same drug — and the same principle applies to PRP. Without standardized, high-quality preparations, clinical trials may be underestimating PRP's true potential.
The shoulder is far more anatomically complex than the elbow. Tennis elbow involves a single tendon at the lateral epicondyle — inject PRP into that one structure and patients often improve dramatically. Rotator cuff disease, by contrast, is a combination of problems: tendinopathy, impingement, partial tears, bursitis, and sometimes acromioclavicular joint pathology. If a patient has multiple pain generators and PRP is injected into only one area, the other contributing conditions remain untreated. This could explain the more modest improvements seen in shoulder studies compared to elbow trials.
Is PRP Safe for Rotator Cuff Treatment?
An important advantage of PRP is its safety profile. Because PRP is derived from the patient's own blood, there is essentially no risk of allergic reaction or immune rejection. Unlike cortisone, which can degrade tendon tissue with repeated use, PRP does not carry this risk. Some studies even suggest that PRP may improve the long-term structural health of the tendons.
If a cortisone injection is administered without ultrasound guidance, the steroid may inadvertently contact the rotator cuff tendons, causing damage that can be difficult to reverse. PRP eliminates this concern entirely.
My Clinical Perspective on PRP for Rotator Cuff Disease
Based on this meta-analysis and my clinical experience, I agree with the authors' conclusion: PRP is a viable alternative to cortisone for conservative treatment of rotator cuff disease. It is clearly not inferior to steroid injections and may offer meaningful advantages in function, tendon health, and reduced need for further procedures.
In my practice, PRP is not yet my universal first-line injection for all rotator cuff problems — we do not yet have the definitive, slam-dunk data that PRP is clearly superior across all subgroups of rotator cuff disease. However, for patients who want to avoid the risks associated with cortisone, who have already had cortisone without lasting benefit, or who have partial tears where tendon health is a priority, PRP is an excellent option that I frequently recommend.
As clinical trials continue to improve in quality — particularly with standardized PRP preparations and more targeted injection protocols — I expect the data to become even more favorable. If you are dealing with persistent rotator cuff pain and want to explore whether PRP therapy is right for you, consider scheduling a consultation to discuss your options.
References
1. Pang L, Xu Y, Li T, Li Y, Zhu J, Tang X. Platelet-Rich Plasma Injection Can Be a Viable Alternative to Corticosteroid Injection for Conservative Treatment of Rotator Cuff Disease: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2023;39(2):402-421.e1. doi:10.1016/j.arthro.2022.06.022
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments